冠状动脉疾病
经皮冠状动脉介入治疗
传统PCI
中医药
医学
计算机辅助设计
药物输送
药品
内科学
重症监护医学
药理学
纳米技术
替代医学
材料科学
心肌梗塞
病理
工程类
工程制图
作者
Rongyuan Yang,GU Ying-ming,Jinying Qin,Qingqing Liu,Qing Liu
出处
期刊:Heliyon
[Elsevier]
日期:2023-09-01
卷期号:9 (9): e19766-e19766
被引量:2
标识
DOI:10.1016/j.heliyon.2023.e19766
摘要
Coronary artery disease (CAD) is a leading cause of death worldwide, while conventional treatments such as percutaneous coronary intervention (PCI) have limitations. This review aims to explore the potential of nanoparticles loaded with Chinese medicine in the treatment of CAD. We conducted a comprehensive literature search to summarize the characteristics of nanovehicle systems, targeting strategies, and administration methods of various nanoparticles containing Chinese medicine for CAD treatment. Nanoparticle-based drug delivery systems, capable of delivering Chinese medicine, offer several advantages, including high targeting efficiency, prolonged half-life, and low systemic toxicity, making them promising for CAD treatment. Overall, nanoparticles containing Chinese medicine present a promising approach for the treatment of CAD.
科研通智能强力驱动
Strongly Powered by AbleSci AI